BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 29, 2009
View Archived Issues
Novel PDE inhibitors in development at Kyorin for the treatment of respiratory disorders
Read More
Schering-Plough announces the development of Aurora kinase inhibitors
Read More
Roche claims novel PI3K inhibitors with potential as anticancer agents
Read More
New chemokine CXCR5 receptor antagonists prepared and tested at sanofi-aventis
Read More
Kyowa Hakko Kirin describes novel antitumor agents
Read More
Lipoic acid slows Alzheimer's disease progression
Read More
Novartis and Medicines for Malaria Venture launch Coartem dispersible
Read More
Oasmia's Paclical shows promising results in patients with severe cancer
Read More
Pixantrone increases progression-free survival in non-Hodgkin's lymphoma trial
Read More
Amgen reviews Q4 progress
Read More
HPIV3/EboGP Ebola vaccine enhanced and tested in vivo
Read More
Cripto blockade enhances embryonic stem cell transplant in Parkinson's disease model
Read More
Gelnique gel approved by the FDA for overactive bladder
Read More
Medarex to initiate trial for first antibody-drug conjugate, MDX-1203
Read More
Chelsea initiates phase II droxidopa trial in fibromyalgia
Read More
Verona obtains regulatory approval for clinical trial of its antiasthma drug RPL-554
Read More
Duska Therapeutics changes company name to Cordex Pharma
Read More
Omeros receives milestone payment from SMRI for development of PDE-10 inhibitors
Read More
Kringle receives approval for ChronSeal CTA and signs option agreement with Maruho
Read More
Alfacell conducts pre-NDA meeting with FDA regarding Onconase for UMM
Read More
Novacea stockholders approve merger with Transcept
Read More
The Medicines Company initiates tender offer for all outstanding shares of Targanta
Read More
FDA allows Clinuvel to begin U.S. clinical trials of afamelanotide
Read More
Boston Scientific's Taxus Liberte drug-eluting stent approved in Japan
Read More
Can-Fite completes patient enrollment in phase II CF-101 dry eye syndrome trial
Read More
FDA advisory panel to review pegloticase BLA for treatment-failure gout
Read More